EA201001286A1 - Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопороза - Google Patents
Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопорозаInfo
- Publication number
- EA201001286A1 EA201001286A1 EA201001286A EA201001286A EA201001286A1 EA 201001286 A1 EA201001286 A1 EA 201001286A1 EA 201001286 A EA201001286 A EA 201001286A EA 201001286 A EA201001286 A EA 201001286A EA 201001286 A1 EA201001286 A1 EA 201001286A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- vitamin
- hydroxivitamine
- bones
- density
- increase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Раскрывается комбинированное применение витамина D (холекальциферола) и 25-ОН D3 (кальцифедиола) для лечения и/или предупреждения остеопороза. Также можно использовать один или несколько бис-фосфонатов для ингибирования резорбции костной ткани. Также раскрываются формы и дозировки фармацевтической композиции, а также способы получения лекарственных средств.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2851008P | 2008-02-13 | 2008-02-13 | |
US3167108P | 2008-02-26 | 2008-02-26 | |
US3692208P | 2008-03-14 | 2008-03-14 | |
US3692808P | 2008-03-15 | 2008-03-15 | |
PCT/EP2009/051639 WO2009101135A1 (en) | 2008-02-13 | 2009-02-12 | Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201001286A1 true EA201001286A1 (ru) | 2010-12-30 |
EA018580B1 EA018580B1 (ru) | 2013-09-30 |
Family
ID=40551383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201001286A EA018580B1 (ru) | 2008-02-13 | 2009-02-12 | Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопороза |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110039809A1 (ru) |
EP (1) | EP2240181A1 (ru) |
JP (1) | JP5509504B2 (ru) |
KR (2) | KR20150103336A (ru) |
CN (2) | CN104758301A (ru) |
AU (1) | AU2009214052B2 (ru) |
BR (1) | BRPI0907951A2 (ru) |
EA (1) | EA018580B1 (ru) |
HK (1) | HK1212210A1 (ru) |
IL (1) | IL207592A0 (ru) |
MX (1) | MX2010008906A (ru) |
WO (1) | WO2009101135A1 (ru) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
DK3095447T3 (da) | 2006-02-03 | 2022-01-31 | Opko Renal Llc | Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3 |
EP2037936B1 (en) | 2006-06-21 | 2014-06-11 | Proventiv Therapeutics, LLC | Method of treating and preventing secondary hyperparathyroidism |
JP5444212B2 (ja) | 2007-04-25 | 2014-03-19 | シトクロマ インコーポレイテッド | ビタミンd不足および欠乏症の治療方法 |
PL3542792T3 (pl) | 2007-04-25 | 2023-11-20 | Eirgen Pharma Ltd. | 25-hydroksywitamina d o kontrolowanym uwalnianiu |
US20110052707A1 (en) * | 2008-02-12 | 2011-03-03 | Neil Robert Buck | Combination of vitamin d and 25-hydroxyvitamin d 3 |
IT1393945B1 (it) * | 2009-04-21 | 2012-05-17 | Fidia Farmaceutici | Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche |
US11672809B2 (en) | 2010-03-29 | 2023-06-13 | Eirgen Pharma Ltd. | Methods and compositions for reducing parathyroid levels |
RU2498811C1 (ru) * | 2012-04-19 | 2013-11-20 | Общество С Ограниченной Ответственностью "Парафарм" | Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей |
RU2497533C1 (ru) * | 2012-04-19 | 2013-11-10 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме) |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
EP3193925A2 (en) * | 2014-08-07 | 2017-07-26 | OPKO Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin d |
DK3090638T3 (da) * | 2015-04-20 | 2020-08-10 | Bernd-Michael Löffler | Kosttilskud til behandling af vitamin-d3-mangelsymptomer |
CR20180510A (es) | 2016-03-28 | 2019-05-15 | Opko Ireland Global Holdings Ltd | Método de tratamiento con vitamina d |
KR102571660B1 (ko) * | 2016-09-23 | 2023-08-25 | 퀸시 바이오사이언스 엘엘씨 | 아포에쿼린 및 비타민 d 함유 조성물 및 이의 사용 방법 |
CN110338425A (zh) * | 2018-04-08 | 2019-10-18 | 北京奥萨医药研究中心有限公司 | 一种防护骨质疏松的营养补充剂 |
CN108720025A (zh) * | 2018-06-08 | 2018-11-02 | 唐飞 | 25-羟基维生素d3在食品中的应用 |
CN108902985A (zh) * | 2018-06-08 | 2018-11-30 | 唐飞 | 25-羟基维生素d3在制备保健食品中的应用 |
IT201900007202A1 (it) * | 2019-05-24 | 2020-11-24 | Pavia Farm S R L | Composizione a base di vitamine liposolubili ad elevato assorbimento enterico |
WO2022224001A1 (en) * | 2021-04-22 | 2022-10-27 | Faes Farma, S.A. | Universal dosage regime of 25-hydroxy vitamin d3 |
CN114088855B (zh) * | 2021-11-16 | 2022-10-28 | 河南农业大学 | 一种肉鸡胫骨软骨发育不良早期诊断粪便生物标志物及其应用 |
CN117503708A (zh) * | 2023-09-27 | 2024-02-06 | 济南维瑞医药科技开发有限公司 | 一种佝偻病患儿专用补钙剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009179A1 (en) * | 1989-02-16 | 1990-08-23 | University Of Georgia Research Foundation, Inc. | Treatment of tibial dyschondroplasia |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US7050832B2 (en) * | 2001-11-28 | 2006-05-23 | Arraycomm Llc | Variable diversity transmission in a radio communications system based on characteristics of a received signal |
US7632518B2 (en) * | 2002-01-15 | 2009-12-15 | Dsm Ip Assets B.V. | 25-hydroxy vitamin D3 compositions |
PL1516540T3 (pl) * | 2003-09-22 | 2013-02-28 | Dsm Ip Assets Bv | Zastosowanie związków z grupy witaminy D |
WO2005027650A1 (en) * | 2003-09-22 | 2005-03-31 | Dsm Ip Assets B.V. | Vitamin containing pet food compositions |
KR20160143887A (ko) * | 2005-08-18 | 2016-12-14 | 디에스엠 아이피 어셋츠 비.브이. | 수컷 동물의 번식력을 향상시키는데 있어서의 25-하이드록시 비타민 d₃의 용도 |
EP1945185B1 (en) * | 2005-10-12 | 2016-02-03 | Proventiv Therapeutics, LLC | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
WO2007059960A1 (en) * | 2005-11-25 | 2007-05-31 | Dsm Ip Assets B.V. | Use of 25-hydroxy vitamin d3 to improve vitality of animals |
DK3095447T3 (da) * | 2006-02-03 | 2022-01-31 | Opko Renal Llc | Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3 |
-
2009
- 2009-02-12 MX MX2010008906A patent/MX2010008906A/es active IP Right Grant
- 2009-02-12 EA EA201001286A patent/EA018580B1/ru not_active IP Right Cessation
- 2009-02-12 EP EP09709664A patent/EP2240181A1/en not_active Withdrawn
- 2009-02-12 CN CN201510114271.4A patent/CN104758301A/zh active Pending
- 2009-02-12 US US12/867,316 patent/US20110039809A1/en not_active Abandoned
- 2009-02-12 CN CN2009801052551A patent/CN101951919A/zh active Pending
- 2009-02-12 KR KR1020157023327A patent/KR20150103336A/ko not_active Application Discontinuation
- 2009-02-12 AU AU2009214052A patent/AU2009214052B2/en active Active
- 2009-02-12 JP JP2010546332A patent/JP5509504B2/ja active Active
- 2009-02-12 BR BRPI0907951-3A patent/BRPI0907951A2/pt not_active Application Discontinuation
- 2009-02-12 WO PCT/EP2009/051639 patent/WO2009101135A1/en active Application Filing
- 2009-02-12 KR KR1020107020288A patent/KR20100126376A/ko active Search and Examination
-
2010
- 2010-08-12 IL IL207592A patent/IL207592A0/en unknown
-
2016
- 2016-01-06 HK HK16100085.8A patent/HK1212210A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP5509504B2 (ja) | 2014-06-04 |
WO2009101135A1 (en) | 2009-08-20 |
KR20100126376A (ko) | 2010-12-01 |
CN104758301A (zh) | 2015-07-08 |
AU2009214052B2 (en) | 2015-05-07 |
MX2010008906A (es) | 2010-11-05 |
EP2240181A1 (en) | 2010-10-20 |
JP2011512343A (ja) | 2011-04-21 |
US20110039809A1 (en) | 2011-02-17 |
HK1212210A1 (en) | 2016-06-10 |
EA018580B1 (ru) | 2013-09-30 |
IL207592A0 (en) | 2010-12-30 |
AU2009214052A1 (en) | 2009-08-20 |
CN101951919A (zh) | 2011-01-19 |
BRPI0907951A2 (pt) | 2015-08-04 |
KR20150103336A (ko) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001286A1 (ru) | Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопороза | |
CL2010001260A1 (es) | Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis. | |
MA33044B1 (fr) | Composition pharmaceutique contenant des derives de glucopyranosyl diphenylmethane, sa forme posologique galenique, son procede de preparation et ses utilisations pour une regulation glycemique amelioree chez un patient | |
JOP20200152A1 (ar) | مركبات حلقية كبرى لعلاج مرض | |
EA201001288A1 (ru) | Лечение гипертонии 25-гидроксивитамином d3 | |
MY157445A (en) | Compounds that modulate intracellular calcium. | |
EA201290184A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
TW200730515A (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
PA8493701A1 (es) | Compuestos para tratar la obesidad | |
MX2009011878A (es) | Compuestos antagonistas de acido ribonucleico para la modulacion de beta-catenina. | |
EA201001847A1 (ru) | Соединения и композиции, применяемые для лечения малярии | |
EA201290139A1 (ru) | Модуляторы кальциевого канала, активируемого высвобождением кальция, представляющие собой производные пиразола, и способы лечения немелкоклеточного рака легких | |
EA201290138A1 (ru) | Производные пиразола как модуляторы кальциевых каналов, активируемых высвобождением кальция | |
EA200900203A1 (ru) | Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение | |
MX2009004699A (es) | Compuestos de piridinona. | |
MX2010002712A (es) | Compuestos que modulan calcio intracelular. | |
UY32919A (es) | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos | |
MX337711B (es) | Compuestos que modulan el calcio intracelular. | |
EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
UA94749C2 (en) | Benzimidazole modulators of vr1 | |
BR112013003847A2 (pt) | métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados | |
EA201200098A1 (ru) | Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия | |
CO6390111A2 (es) | Productos sanguíneos deshidratados por aspersión y métodos para elaborar los mismos | |
EA200702212A1 (ru) | Способ лечения или профилактики разрушения кости или остеопороза | |
EA201300988A1 (ru) | Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |